Predictors of CD4 eligibility for antiretroviral therapy initiation among hiv-infected pregnant women in Lusaka, Zambia

Journal of Acquired Immune Deficiency Syndromes

Volumn 57, Issue 5, 2011, Pages

  Liu, Katherine C ^a,b   Mulindwa, Jessica ^c   Giganti, Mark J ^a,b   Putta, Nande B ^a   Chintu, Namwinga ^a   Chi, Benjamin H ^a,b   Stringer, Jeffrey S A ^a,b   Stringer, Elizabeth M ^a,b  

^a CENTRE FOR INFECTIOUS DISEASE RESEARCH IN ZAMBIA   (Zambia)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^c UNIVERSITY OF ZAMBIA   (Zambia)

Author keywords

antiretroviral therapy eligibility; CD4; HIV; PMTCT; predictor; pregnancy

Indexed keywords

HEMOGLOBIN;

ADULT; ALGORITHM; ANTIVIRAL THERAPY; ARTICLE; BODY WEIGHT; CD4 LYMPHOCYTE COUNT; FEMALE; GESTATIONAL AGE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MATERNAL AGE; PREGNANT WOMAN; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; TUBERCULOSIS; ZAMBIA;

ADULT; AGE FACTORS; ANTI-HIV AGENTS; CD4 LYMPHOCYTE COUNT; EDUCATIONAL STATUS; FEMALE; GESTATIONAL AGE; HEMOGLOBINS; HIV INFECTIONS; HUMANS; LOGISTIC MODELS; MODELS, BIOLOGICAL; PREDICTIVE VALUE OF TESTS; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PRENATAL CARE; RETROSPECTIVE STUDIES; RISK FACTORS; ZAMBIA;

EID: 80051549580     PISSN: 15254135     EISSN: 10779450     Source Type: Journal    
DOI: 10.1097/QAI.0b013e31821d3507     Document Type: Article

References (26)

1. 2009 AIDS Epidemic Update: Geneva. Joint United Nations Programme on HIV/AIDS. Vol 1. Geneva, Switzerland; 2009:1-100.
2. Sturt AS, Dokubo EK, Sint TT. Antiretroviral therapy (ART) for treating HIV infection in ART-eligible pregnant women. Cochrane Database Syst Rev. (3):CD008440. 2010.
3. CooperER, CharuratM,Mofenson L, et al.Combination antiretroviral strategies for the treatment of pregnant HIV-1-infected women and prevention of perinatal HIV-1 transmission. J Acquir Immune Defic Syndr. 2002;29:484-494. (Pubitemid 34456340)
4. Ekouevi DK, Coffie PA, Becquet R, et al. Antiretroviral therapy in pregnant women with advanced HIV disease and pregnancy outcomes in Abidjan, Cote d'Ivoire. AIDS. 2008;22:1815-1820.
5. WHO MTCT Collaborative Study Team. Rapid Advice: Use of Antiretroviral Drugs for Treating Pregnant Women and Preventing HIV Infection in Infants. Vol 1. Geneva, Switzerland: WHO; 2009:1-26.
6. Bicego G, Boerma JT, Ronsmans C. The effect of AIDS on maternal mortality in Malawi and Zimbabwe. AIDS. 2002;16:1078-1081. (Pubitemid 34499436)
7. Sewankambo NK, Gray RH, Ahmad S, et al. Mortality associated with HIV infection in rural Rakai District, Uganda. AIDS. 2000;14:2391-2400.
8. McIntyre J. Maternal health and HIV. Reprod Health Matters. 2005;13: 129-135. (Pubitemid 40813259)
9. Kuhn L, Aldrovandi GM, Sinkala M, et al. Potential impact of new WHO criteria for antiretroviral treatment for prevention of mother-to-child HIV transmission. AIDS. 2010;24:1374-1377.
10. Kuhn L, Aldrovandi GM, Sinkala M, et al. Differential effects of early weaning for HIV-free survival of children born to HIV-infected mothers by severity of maternal disease. PLoS One. 2009;4:e6059.
11. Ministry of Health. National Protocol Guidelines: Integrated Prevention of Mother to Child Transmission of HIV/AIDS. Lusaka, Zambia: Ministry of Health; 2008.
12. World Health Organization. Towards Universal Access: Scaling Up Priority HIV/AIDS Interventions in the Health Sector. Geneva: WHO; 2008.
13. Mandala J, Torpey K, Kasonde P, et al. Prevention of mother-to-child transmission of HIV in Zambia: implementing efficacious ARV regimens in primary health centers. BMC Public Health. 2009;9:314.
14. Stringer EM, Sinkala M, Stringer JS, et al. Prevention of mother-tochild transmission of HIV in Africa: successes and challenges in scaling-up a nevirapine-based program in Lusaka, Zambia. AIDS. 2003; 17:1377-1382. (Pubitemid 36819852)
15. Kuhn L, Aldrovandi GM, Sinkala M, et al. Effects of early, abrupt weaning on HIV-free survival of children in Zambia. N Engl J Med. 2008;359: 130-141. (Pubitemid 351962036)
16. Stinson K, Boulle A, Coetzee D, et al. Initiation of highly active antiretroviral therapy among pregnant women in Cape Town, South Africa. Trop Med Int Health. 2010;15:825-832.
17. Carter RJ, Dugan K, El-Sadr WM, et al. CD4+ cell count testing more effective than HIV disease clinical staging in identifying pregnant and postpartum women eligible for antiretroviral therapy in resource-limited settings. J Acquir Immune Defic Syndr. 2010;55:404-410.
18. Brown ER, Otieno P, Mbori-Ngacha DA, et al. Comparison of CD4 cell count, viral load, and other markers for the prediction of mortality among HIV-1-infected Kenyan pregnant women. J Infect Dis. 2009;199: 1292-1300.
19. Nguyen RH, Gange SJ, Serwadda D, et al. Screening HIV-positive pregnant women for antiretroviral therapy: utility of self-reported symptoms. Int J STD AIDS. 2006;17:112-115.
20. Kishk NA. Knowledge, attitudes and practices of women towards antenatal care: rural-urban comparison. J Egypt Public Health Assoc. 2002;77:479-498.
21. Kigozi IM, Dobkin LM, Martin JN, et al. Late-disease stage at presentation to an HIV clinic in the era of free antiretroviral therapy in sub-Saharan Africa. J Acquir Immune Defic Syndr. 2009;52: 280-289.
22. O'Brien ME, Kupka R, Msamanga GI, et al. Anemia is an independent predictor of mortality and immunologic progression of disease among women with HIV in Tanzania. J Acquir Immune Defic Syndr. 2005;40: 219-225. (Pubitemid 41395722)
23. Karon JM, Fleming PL, Steketee RW, et al. HIV in the United States at the turn of the century: an epidemic in transition. Am J Public Health. 2001; 91:1060-1068. (Pubitemid 32574829)
24. Zolfo M, DeWeggheleire A, Schouten E, et al. Time for "test and treat" in prevention of mother-to-child transmission programs in low-and middleincome countries. J Acquir Immune Defic Syndr. 2010;55:287-289.
25. Harrington M, Carpenter CC. Hit HIV-1 hard, but only when necessary. Lancet. 2000;355:2147-2152. (Pubitemid 30364669)
26. Peter T, Badrichani A, Wu E, et al. Challenges in implementing CD4 testing in resource-limited settings. Cytometry B Clin Cytom. 2008; 74(suppl 1):S123-S130. (Pubitemid 351569280)